Santen is a pharmaceutical company dedicated purely to ophthalmology, working with Allergy UK to help improve understanding of the rare allergic eye condition Vernal Keratoconjunctivitis (VKC). VKC is most common in children and adolescents, starting usually before 10 years of age, most frequently in boys. Seasonal exacerbations usually occur, but the condition may be active year-round, causing inflammation of the surface of the eye. Without adequate treatment, the symptoms of VKC – including intense itching, painful eyes and light sensitivity – can place a huge burden on those affected.
Santen carries out research and development of prescription medicines, over-the-counter products and devices. For more information, please visit www.santen.eu